# Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis

> **NCT01566552** · PHASE4 · UNKNOWN · sponsor: **Banaras Hindu University** · enrollment: 1300 (estimated)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DRUG:** AMBISOME

## Key facts

- **NCT ID:** NCT01566552
- **Lead sponsor:** Banaras Hindu University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2014-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566552, "Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01566552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*